Drug profile · INN
faldaprevir
FALDAPREVIR BOEHRINGER INGELHEIM
faldaprevir (FALDAPREVIR BOEHRINGER INGELHEIM) is a hepatitis c virus serine protease, ns3/ns4a inhibitor.
EMA: application withdrawn Antiinfectives for systemic use (J05) J05AE
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — faldaprevir
- Class
- Antiinfectives for systemic use (J05)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
faldaprevir (FALDAPREVIR BOEHRINGER INGELHEIM) is a hepatitis c virus serine protease, ns3/ns4a inhibitor.
Key facts
INN faldaprevir
Brand FALDAPREVIR BOEHRINGER INGELHEIM
Mechanism Hepatitis C virus serine protease, NS3/NS4A inhibitor
Target Hepatitis C virus serine protease, NS3/NS4A
Therapeutic class Antiinfectives for systemic use (J05)
ATC code J05AE
Mechanism of action
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Primary target: Hepatitis C virus serine protease, NS3/NS4A
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is faldaprevir?
faldaprevir (FALDAPREVIR BOEHRINGER INGELHEIM) is a hepatitis c virus serine protease, ns3/ns4a inhibitor.
What is the brand name for faldaprevir?
FALDAPREVIR BOEHRINGER INGELHEIM is a marketed brand name for faldaprevir. Check FDA Drugs@FDA for the current US label holder and prescribing information.